nach oben

Erschienen in:

01.09.2009 | Original Article

A combined histologic and molecular approach identifies three groups of gastric cancer with different prognosis

verfasst von: Enrico Solcia, Catherine Klersy, Luca Mastracci, Paola Alberizzi, Maria Elena Candusso, Marta Diegoli, Francesca Tava, Roberta Riboni, Rachele Manca, Ombretta Luinetti

Erschienen in: Virchows Archiv | Ausgabe 3/2009

Einloggen, um Zugang zu erhalten

Abstract

The limited prognostic value of currently used histologic classifications of gastric cancer and their failure to account for the complexity of the disease as revealed by more recent investigations prompted a combined reinvestigation of histologic, molecular, and clinicopathologic patterns in 294 extensively sampled, invasive gastric cancers representing all main histotypes and stages of the disease and followed for a median of 150 months. Among histologic parameters tested, only cellular atypia, angio-lympho- or neuroinvasion, Ki67 proliferation index, expansile/infiltrative type growth, and T8 cell-rich high lymphoid intra-/peritumor response (HLR) proved to be stage-independent predictors of patient survival. Among molecular tests, p53 gene exon 7 (loop 3) and 8 (loop-sheet-helix motif and S-10 band), but not p53 protein overexpression, TP53 LOH or 18qLOH, were found to worsen prognosis. Microsatellite DNA instability was a favorable prognostic factor when coupled with HLR. Patient survival analysis of the main histotypes and their subtypes confirmed the favorable prognosis of HLR, well-differentiated tubular, muconodular, and low grade diffuse desmoplastic cancers, and highlighted the worse prognosis of anaplastic and infiltrative-lymphoinvasive mucinous cancers compared to ordinary cohesive and diffuse cancers. Distinct roles of individual morphologic and molecular factors in tumor progression of the different histotypes have been recognized. The combination of survival-predictive histotypes and individual histologic or molecular parameters allowed us to develop a classification of all gastric cancers into three grades of increasing malignancy which proved to be of high prognostic value.

Ribeiro MM, Seixas M, Sobrinho-Simoes M (1988) Prognosis in gastric carcinoma. The preeminence of staging and futility of histological classification. Dig Dis Pathol 1:51–68

Carneiro F, Seixas M, Sobrinho-Simoes M (1995) New elements for an updated classification of the carcinomas of the stomach. Pathol Res Pract 191:571–584PubMed

Chiaravalli AM, Cornaggia M, Furlan D et al (2001) The role of histological investigation in prognostic evaluation of advanced gastric cancer. Analysis of histological structure and molecular changes compared with invasive pattern and stage. Virchows Arch 439:158–169PubMedCrossRef

Lauren P (1965) The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand 64:31–49PubMed

Esaki Y, Hirayama R, Hirokawa K (1990) A comparison of patterns of metastasis in gastric cancer by histologic type and age. Cancer 65:2086–2090PubMedCrossRef

Uchino S, Noguchi M, Ochiai A, Saito T, Kobayashi M, Hirohashi S (1993) P53 Mutation in gastric cancer: a genetic model for carcinogenesis is common to gastric and colorectal cancer. Int J Cancer 54:759–764PubMedCrossRef

Becker KF, Atkinson MJ, Reich U, Becker I, Nekarda H, Siewert JR, Hofler H (1994) E-cadherin gene mutations provide clues to diffuse type gastric carcinomas. Cancer Res 54:3845–3852PubMed

Ranzani GN, Luinetti O, Padovan LS et al (1995) p53 gene mutations and protein nuclear accumulation are early events in intestinal type gastric cancer but late events in diffuse type. Cancer Epidemiol Biomarkers Prev 4:223–231PubMed

Solcia E, Fiocca R, Luinetti O et al (1996) Intestinal and diffuse gastric cancers arise in a different background of Helicobacter pylori gastritis through different gene involvement. Am J Surg Pathol 20(Suppl 1):S8–S22PubMed

10.

Oliveira C, Seruca R, Seixas M, Sobrinho-Simoes M (1998) The clinicopathological features of gastric carcinomas with microsatellite instability may be mediated by mutations of different “target genes”: a study of the TGFbeta RII, IGFII R, and BAX genes. Am J Pathol 153:1211–1219PubMed

11.

Yamamoto H, Perez-Piteira J, Yoshida T et al (1999) Gastric cancers of the microsatellite mutator phenotype display characteristic genetic and clinical features. Gastroenterology 116:1348–1357PubMedCrossRef

12.

Candusso ME, Luinetti O, Villani L et al (2002) Loss of heterozygosity at 18q21 region in gastric cancer involves a number of cancer-related genes and correlates with stage and histology, but lacks independent prognostic value. J Pathol 197:44–50PubMedCrossRef

13.

Stemmermann GN, Brown C (1974) A survival study of intestinal and diffuse types of gastric carcinoma. Cancer 33:1190–1195PubMedCrossRef

14.

Ming SC (1977) Gastric carcinoma. A pathobiological classification. Cancer 39:2475–2485PubMedCrossRef

15.

Kubo T (1971) Histologic appearance of gastric carcinoma in high and low mortality countries: comparison between Kyushu, Japan and Minnesota, USA. Cancer 28:726–734PubMedCrossRef

16.

Watanabe H, Jass JR and Sobin LH in collaboration with pathologists in eight countries (1990) Histological typing of oesophageal and gastric tumors, 2nd ed. Edited by the World Health Organization (WHO). Springer, Berlin, pp. 20–26

17.

Goseki N, Takizawa T, Koike M (1992) Differences in the mode of the extension of gastric cancer classified by histological type: new histological classification of gastric carcinoma. Gut 33:606–612PubMedCrossRef

18.

Martin IG, Dixon MF, Sue-Ling H, Axon AT, Johnston D (1994) Goseki histological grading of gastric cancer is an important predictor of outcome. Gut 35:758–763PubMedCrossRef

19.

Songun I, van de Velde CJ, Arends JW et al (1999) Classification of gastric carcinoma using the Goseki system provides prognostic information additional to TNM staging. Cancer 85:2114–2118PubMedCrossRef

20.

Gabbert HE, Meier S, Gerharz CD, Hommel G (1991) Incidence and prognostic significance of vascular invasion in 529 gastric-cancer patients. Int J Cancer 49:203–207PubMedCrossRef

21.

Watanabe H, Enjoji M, Imai T (1976) Gastric carcinoma with lymphoid stroma. Its morphologic characteristics and prognostic correlations. Cancer 38:232–243PubMedCrossRef

22.

Minamoto T, Mai M, Watanabe K et al (1990) Medullary carcinoma with lymphocytic infiltration of the stomach. Clinicopathologic study of 27 cases and immunohistochemical analysis of the subpopulations of infiltrating lymphocytes in the tumor. Cancer 66:945–952PubMedCrossRef

23.

Grogg KL, Lohse CM, Pankratz VS, Halling KC, Smyrk TC (2003) Lymphocyte-rich gastric cancer: associations with Epstein–Barr virus, microsatellite instability, histology, and survival. Mod Pathol 16:641–651PubMedCrossRef

24.

Chiaravalli AM, Feltri M, Bertolini V et al (2006) Intratumour T cells, their activation status and survival in gastric carcinomas characterised for microsatellite instability and Epstein–Barr virus infection. Virchows Arch 448:344–353PubMedCrossRef

25.

Nakamura S, Ueki T, Yao T, Ueyama T, Tsuneyoshi M (1994) Epstein–Barr virus in gastric carcinoma with lymphoid stroma. Special reference to its detection by the polymerase chain reaction and in situ hybridization in 99 tumors, including a morphologic analysis. Cancer 73:2239–2249PubMedCrossRef

26.

Shiao YH, Palli D, Caporaso NE et al (2000) Genetic and immunohistochemical analyses of p53 independently predict regional metastasis of gastric cancers. Cancer Epidemiol Biomarkers Prev 9:631–633PubMed

27.

Inoue H, Matsuyama A, Mimori K, Ueo H, Mori M (2002) Prognostic score of gastric cancer determined by cDNA microarray. Clin Cancer Res 8:3475–3479PubMed

28.

Xiangming C, Natsugoe S, Takao S et al (2001) Preserved Smad4 expression in the transforming growth factor beta signaling pathway is a favorable prognostic factor in patients with advanced gastric cancer. Clin Cancer Res 7:277–282PubMed

29.

Kim YH, Lee HS, Lee HJ et al (2004) Prognostic significance of the expression of Smad4 and Smad7 in human gastric carcinomas. Ann Oncol 15:574–580PubMedCrossRef

30.

Yonemura Y, Ninomiya I, Ohoyama S et al (1991) Expression of c-erbB-2 oncoprotein in gastric carcinoma. Immunoreactivity for c-erbB-2 protein is an independent indicator of poor short-term prognosis in patients with gastric carcinoma. Cancer 67:2914–2918PubMedCrossRef

31.

Weiss MM, Kuipers EJ, Postma C et al (2004) Genomic alterations in primary gastric adenocarcinomas correlate with clinicopathological characteristics and survival. Cell Oncol 26:307–317PubMed

32.

Endoh Y, Tamura G, Motoyama T, Ajioka Y, Watanabe H (1999) Well-differentiated adenocarcinoma mimicking complete-type intestinal metaplasia in the stomach. Hum Pathol 30:826–832PubMedCrossRef

33.

Solcia E, Luinetti O, Tava F et al (2004) Identification of a lower grade muconodular subtype of gastric mucinous cancer. Virchows Arch 445:572–579PubMedCrossRef

34.

Chiaravalli AM, Klersy C, Tava F et al (2009) Lower and higher grade subtypes of diffuse gastric cancer. Human Pathol (in press). doi:10.1016/j.humpath.2009.04.004

35.

Matsui K, Kitagawa M, Miwa A, Kuroda Y, Tsuji M (1991) Small cell carcinoma of the stomach: a clinicopathologic study of 17 cases. Am J Gastroenterol 86:1167–1175PubMed

36.

Rindi G, Azzoni C, La Rosa S et al (1999) ECL cell tumor and poorly differentiated endocrine carcinoma of the stomach: prognostic evaluation by pathological analysis. Gastroenterology 116:532–542PubMedCrossRef

37.

Jiang SX, Mikami T, Umezawa A, Saegusa M, Kameya T, Okayasu I (2006) Gastric large cell neuroendocrine carcinomas: a distinct clinicopathologic entity. Am J Surg Pathol 30:945–953PubMedCrossRef

38.

Krulewski T, Cohen LB (1988) Choriocarcinoma of the stomach: pathogenesis and clinical characteristics. Am J Gastroenterol 83:1172–1175PubMed

39.

Nagai E, Ueyama T, Yao T, Tsuneyoshi M (1993) Hepatoid adenocarcinoma of the stomach. A clinicopathologic and immunohistochemical analysis. Cancer 72:1827–1835PubMedCrossRef

40.

Sobin LH, Wittekind C (1997) TNM classification of malignant tumors, 5th edn. Wiley-Liss, New York, pp 59–62

41.

Boland CR, Thibodeau SN, Hamilton SR et al (1998) A national cancer institute workshop on microsatellite instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 58:5248–5257PubMed

42.

Vogelstein B, Fearon ER, Hamilton SR et al (1988) Genetic alterations during colorectal tumor development. N Engl J Med 319:525–532PubMed

43.

Elston CW, Ellis IO (1991) Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 19:403–410PubMedCrossRef

44.

Stalsberg H, Hartmann WH (2000) The delimitation of tubular carcinoma of the breast. Hum Pathol 31:601–607PubMedCrossRef

45.

Huang C, Taki T, Adachi M, Konishi T, Higashiyama M, Miyake M (1998) Mutations in exon 7 and 8 of p53 as poor prognostic factors in patients with non-small cell lung cancer. Oncogene 16:2469–2477PubMedCrossRef

46.

Skaug V, Ryberg D, Kure EH et al (2000) P53 Mutations in defined structural and functional domains are related to poor clinical outcome in non-small cell lung cancer patients. Clin Cancer Res 6:1031–1037PubMed

47.

Erber R, Conradt C, Homann N et al (1998) TP53 DNA contact mutations are selectively associated with allelic loss and have a strong clinical impact in head and neck cancer. Oncogene 16:1671–1679PubMedCrossRef

48.

Borresen-Dale AL, Lothe RA, Meling GI, Hainaut P, Rognum TO, Skovlund E (1998) TP53 and long-term prognosis in colorectal cancer: mutations in the L3 zinc-binding domain predict poor survival. Clin Cancer Res 4:203–210PubMed

49.

Cho Y, Gorina S, Jeffrey PD, Pavletich NP (1994) Crystal structure of a p53 tumor suppressor–DNA complex: understanding tumorigenic mutations. Science 265:346–355PubMedCrossRef

50.

Guidoboni M, Gafa R, Viel A et al (2001) Microsatellite instability and high content of activated cytotoxic lymphocytes identify colon cancer patients with a favorable prognosis. Am J Pathol 159:297–304PubMed

51.

dos Santos NR, Seruca R, Constancia M, Seixas M, Sobrinho-Simoes M (1996) Microsatellite instability at multiple loci in gastric carcinoma: clinicopathologic implications and prognosis. Gastroenterology 110:38–44PubMedCrossRef

52.

Saiki Y, Ohtani H, Naito Y, Miyazawa M, Nagura H (1996) Immunophenotypic characterization of Epstein–Barr virus-associated gastric carcinoma: massive infiltration by proliferating CD8+ T-lymphocytes. Lab Invest 75:67–76PubMed

53.

van Beek J, zur Hausen A, Snel SN et al (2006) Morphological evidence of an activated cytotoxic T-cell infiltrate in EBV-positive gastric carcinoma preventing lymph node metastases. Am J Surg Pathol 30:59–65PubMedCrossRef

54.

Ciernik IF, Berzofsky JA, Carbone DP (1996) Human lung cancer cells endogenously expressing mutant p53 process and present the mutant epitope and are lysed by mutant-specific cytotoxic T lymphocytes. Clin Cancer Res 2:877–882PubMed

55.

Vierboom MP, Nijman HW, Offringa R et al (1997) Tumor eradication by wild-type p53-specific cytotoxic T lymphocytes. J Exp Med 186:695–704PubMedCrossRef

56.

Koriyama C, Akiba S, Itoh T et al (2002) Prognostic significance of Epstein–Barr virus involvement in gastric carcinoma in Japan. Int J Mol Med 10:635–639PubMed

57.

Adachi Y, Mori M, Kido A, Shimono R, Maehara Y, Sugimachi K (1992) A clinicopathologic study of mucinous gastric carcinoma. Cancer 69:866–871PubMedCrossRef

58.

Wu CY, Yeh HZ, Shih RT, Chen GH (1998) A clinicopathologic study of mucinous gastric carcinoma including multivariate analysis. Cancer 83:1312–1318PubMedCrossRef

59.

Park JM, Jang YJ, Kim JH et al (2008) Gastric cancer histology: clinicopathologic characteristics and prognostic value. J Surg Oncol 98:520–525PubMedCrossRef

Titel: A combined histologic and molecular approach identifies three groups of gastric cancer with different prognosis
verfasst von: Enrico Solcia
Catherine Klersy
Luca Mastracci
Paola Alberizzi
Maria Elena Candusso
Marta Diegoli
Francesca Tava
Roberta Riboni
Rachele Manca
Ombretta Luinetti
Publikationsdatum: 01.09.2009
Verlag: Springer-Verlag
Erschienen in: Virchows Archiv / Ausgabe 3/2009
Print ISSN: 0945-6317
Elektronische ISSN: 1432-2307
DOI: https://doi.org/10.1007/s00428-009-0813-z

Neu im Fachgebiet Pathologie

01.04.2024 | Forensische Traumatologie | CME

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

A combined histologic and molecular approach identifies three groups of gastric cancer with different prognosis

Abstract

Neu im Fachgebiet Pathologie

Theoretische Grundlagen von Explosionen und Explosionsverletzungen

Auswirkungen vorgeschalteter Laborprozesse auf die Digitalisierung histologischer Schnittpräparate

Knochenmarkhistologie bei Zytopenien

Herausforderungen der Automation bei der quantitativen Auswertung von Leberbiopsien

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2009

Loss of RKIP expression is associated with poor survival in GISTs

Fibroadenoma and intraduct papilloma—a common pathogenesis?

DLK is a novel immunohistochemical marker for adrenal gland tumors

Neutrophil gelatinase-associated lipocalin (NGAL/Lcn2) is upregulated in gastric mucosa infected with Helicobacter pylori

High resolution analysis of DNA copy-number aberrations of chromosomes 8, 13, and 20 in gastric cancers

Diffuse large B-cell lymphoma with a high number of epithelioid histiocytes (lymphoepithelioid B-cell lymphoma): a study of Osaka Lymphoma Study Group

Neu im Fachgebiet Pathologie

Theoretische Grundlagen von Explosionen und Explosionsverletzungen

Auswirkungen vorgeschalteter Laborprozesse auf die Digitalisierung histologischer Schnittpräparate

Knochenmarkhistologie bei Zytopenien

Herausforderungen der Automation bei der quantitativen Auswertung von Leberbiopsien